Membrane-bound Delta-4 Notch ligand reduces the proliferative activity of primitive human hematopoietic CD34+CD38low cells while maintaining their LTC-IC potential (original) (raw)
Orkin SH . Diversification of haematopoietic stem cells to specific lineages. Nat Rev Genet 2000; 1: 57–64. ArticleCASPubMed Google Scholar
Nye JS, Kopan R . Developmental signaling. Vertebrate ligands for Notch. Curr Biol 1995; 5: 966–969. ArticleCASPubMed Google Scholar
Milner LA, Bigas A . Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. Blood 1999; 93: 2431–2448. CASPubMed Google Scholar
Anderson AC, Robey EA, Huang YH . Notch signaling in lymphocyte development. Curr Opin Genet Dev 2001; 11: 554–560. ArticleCASPubMed Google Scholar
Karanu FN, Murdoch B, Gallacher L, Wu DM, Koremoto M, Sakano S et al. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J Exp Med 2000; 192: 1365–1372. ArticleCASPubMedPubMed Central Google Scholar
Karanu FN, Murdoch B, Miyabayashi T, Ohno M, Koremoto M, Gallacher L et al. Human homologues of Delta-1 and Delta-4 function as mitogenic regulators of primitive human hematopoietic cells. Blood 2001; 97: 1960–1967. ArticleCASPubMed Google Scholar
Tsai S, Fero J, Bartelmez S . Mouse Jagged2 is differentially expressed in hematopoietic progenitors and endothelial cells and promotes the survival and proliferation of hematopoietic progenitors by direct cell-to-cell contact. Blood 2000; 96: 950–957. CASPubMed Google Scholar
Stier S, Cheng T, Dombkowski D, Carlesso N, Scadden DT . Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood 2002; 99: 2369–2378. ArticleCASPubMed Google Scholar
Varnum-Finney B, Xu L, Brashem-Stein C, Nourigat C, Flowers D, Bakkour S et al. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat Med 2000; 6: 1278–1281. ArticleCASPubMed Google Scholar
Ohishi K, Varnum-Finney B, Bernstein ID . Delta-1 enhances marrow and thymus repopulating ability of human CD34(+)CD38(−) cord blood cells. J Clin Invest 2002; 110: 1165–1174. ArticleCASPubMedPubMed Central Google Scholar
Varnum-Finney B, Brashem-Stein C, Bernstein ID . Combined effects of Notch signaling and cytokines induce a multiple log increase in precursors with lymphoid and myeloid reconstituting ability. Blood 2002; 101: 1784–1789. ArticlePubMed Google Scholar
Varnum-Finney B, Purton L, Yu M, Brashem-Stein C, Flowers D, Staats S et al. The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood 1998; 91: 4084–4091. CASPubMed Google Scholar
Jones P, May G, Healy L, Brown J, Hoyne G, Delassus S et al. Stromal expression of Jagged 1 promotes colony formation by fetal hematopoietic progenitor cells. Blood 1998; 92: 1505–1511. CASPubMed Google Scholar
Carlesso N, Aster JC, Sklar J, Scadden DT . Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics. Blood 1999; 93: 838–848. CASPubMed Google Scholar
Walker L, Lynch M, Silverman S, Fraser J, Boulter J, Weinmaster G et al. The Notch/Jagged pathway inhibits proliferation of human hematopoietic progenitors in vitro. Stem Cells 1999; 17: 162–171. ArticleCASPubMed Google Scholar
Han W, Ye Q, Moore MA . A soluble form of human Delta-like-1 inhibits differentiation of hematopoietic progenitor cells. Blood 2000; 95: 1616–1625. CASPubMed Google Scholar
Rao PK, Dorsch M, Chickering T, Zheng G, Jiang C, Goodearl A et al. Isolation and characterization of the notch ligand delta4. Exp Cell Res 2000; 260: 379–386. ArticleCASPubMed Google Scholar
Shutter JR, Scully S, Fan W, Richards WG, Kitajewski J, Deblandre GA et al. Dll4, a novel Notch ligand expressed in arterial endothelium. Genes Dev 2000; 14: 1313–1318. CASPubMedPubMed Central Google Scholar
Yoneya T, Tahara T, Nagao K, Yamada Y, Yamamoto T, Osawa M et al. Molecular cloning of Delta-4, a new mouse and human notch ligand. J Biochem (Tokyo) 2001; 129: 27–34. ArticleCAS Google Scholar
Hawley RG, Lieu FH, Fong AZ, Hawley TS . Versatile retroviral vectors for potential use in gene therapy. Gene Therapy 1994; 1: 136–138. CASPubMed Google Scholar
Dugray A, Geay JF, Foudi A, Bonnet ML, Vainchenker W, Wendling F et al. Rapid generation of a tetracycline-inducible BCR-ABL defective retrovirus using a single autoregulatory retroviral cassette. Leukemia 2001; 15: 1658–1662. ArticleCASPubMed Google Scholar
Landreth KS, Dorshkind K . Pre-B cell generation potentiated by soluble factors from a bone marrow stromal cell line. J Immunol 1988; 140: 845–852. CASPubMed Google Scholar
Bennaceur-Griscelli A, Tourino C, Izac B, Vainchenker W, Coulombel L . Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34+CD38low/neg human bone marrow cells. Blood 1999; 94: 529–538. CASPubMed Google Scholar
Bennaceur-Griscelli A, Pondarre C, Schiavon V, Vainchenker W, Coulombel L . Stromal cells retard the differentiation of CD34(+)CD38(low/neg) human primitive progenitors exposed to cytokines independent of their mitotic history. Blood 2001; 97: 435–441. ArticleCASPubMed Google Scholar
Croisille L, Auffray I, Katz A, Izac B, Vainchenker W, Coulombel L . Hydrocortisone differentially affects the ability of murine stromal cells and human marrow-derived adherent cells to promote the differentiation of CD34++/CD38- long-term culture-initiating cells. Blood 1994; 84: 4116–4124. CASPubMed Google Scholar
Robin C, Pflumio F, Vainchenker W, Coulombel L . Identification of lymphomyeloid primitive progenitor cells in fresh human cord blood and in the marrow of nonobese diabetic-severe combined immunodeficient (NOD-SCID) mice transplanted with human CD34(+) cord blood cells. J Exp Med 1999; 189: 1601–1610. ArticleCASPubMedPubMed Central Google Scholar
Hao Q, Zhu J, Price MA, Payne KJ, Barsky LW, Crooks GM . Identification of a novel, human multilymphoid progenitor in cord blood. Blood 2001; 97: 3683–3690. ArticleCASPubMed Google Scholar
Petzer AL, Hogge DE, Landsdorp PM, Reid DS, Eaves CJ . Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 1996; 93: 1470–1474. ArticleCASPubMedPubMed Central Google Scholar
Ohishi K, Varnum-Finney B, Flowers D, Anasetti C, Myerson D, Bernstein ID . Monocytes express high amounts of Notch and undergo cytokine specific apoptosis following interaction with the Notch ligand, Delta-1. Blood 2000; 95: 2847–2854. CASPubMed Google Scholar
Ohishi K, Varnum-Finney B, Serda RE, Anasetti C, Bernstein ID . The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells. Blood 2001; 98: 1402–1407. ArticleCASPubMed Google Scholar
Dorsch M, Zheng G, Yowe D, Rao P, Wang Y, Shen Q et al. Ectopic expression of Delta4 impairs hematopoietic development and leads to lymphoproliferative disease. Blood 2002; 100: 2046–2055. CASPubMed Google Scholar
Sriuranpong V, Borges M, Ravi R, Arnold D, Nelkin B, Baylin S et al. Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res 2001; 61: 3200–3205. CASPubMed Google Scholar
Ronchini C, Capobianco AJ . Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic). Mol Cell Biol 2001; 21: 5925–5934. ArticleCASPubMedPubMed Central Google Scholar
Kollet O, Peled A, Byk T, Ben-Hur H, Greiner D, Shultz L et al. beta2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 2000; 95: 3102–3105. CASPubMed Google Scholar
Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K et al. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002; 100: 3175–3182. ArticleCASPubMed Google Scholar
Zandstra PW, Lauffenburger DA, Eaves CJ . A ligand–receptor signaling threshold model of stem cell differentiation control: a biologically conserved mechanism applicable to hematopoiesis. Blood 2000; 96: 1215–1222. CASPubMed Google Scholar